A NJ senator and BIO are beating the drum to reinstitute a law that would channel millions into small life science companies around the country.
A NJ senator and BIO are beating the drum to reinstitute a law that would channel millions into small life science companies around the country.
A former Sanofi research scientist is sentenced to 18 months in prison for stealing trade secrets.
GlaxoSmithKline and Johnson & Johnson contribute a total of $100 million to early-stage biotech endeavors.
The FDA considers making some drugs for diabetes, asthma, and other ailments available over the counter.
Two key patent cases that no doubt will impact the future of personalized medicine are pending review by the US Supreme Court. What will the Court decide?
Pharmaceutical companies should deploy cash to fund struggling biotech companies, which could generate much needed new drugs.
Despite nervous investors and a volatile market, a courageous few biotechnology companies are taking their chances on Wall Street.
How to successfully surmount the challenges women face in becoming biotech industry leaders
New York City major names Cornell University as the winner of the year-long competition for rights to build a new sci-tech research facility in the city.
A roundup of eight biotech companies that didn’t make it through this year's continuing tough economic times